B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Tg100 115

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tg100 115, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

pi
22 shared targets
ruxolitinib
36 shared targets
gsk
18 shared targets
gsk
22 shared targets
bi
27 shared targets
su
49 shared targets
r
51 shared targets
pictilisib
24 shared targets · score 46.2
kw
52 shared targets
ruboxistaurin
29 shared targets
Loading evidence profile...

This evidence profile for Tg100 115 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.